ReviewFrontiers in bioengineering and biotechnology2018

Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.

Antonio Cervadoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.